Bioenvision/Genzyme drug achieves responses in leukemia
In a UK National Cancer Research Institute multi-center study of older patients with acute myeloid leukemia (AML) who were unsuitable for intensive chemotherapy, the overall response for clofarabine
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.